Joris Winderickx
Corporate Officer/Principal bei reMYND NV
Profil
Joris Winderickx is the founder of reMYND NV, where he currently serves as the Scientific Advisor since 2012.
He founded the company in 2002.
Dr. Winderickx is also the founder of Royal Flemish Chemical Society.
Dr. Winderickx's former job includes being a Director at ADx NeuroSciences NV.
Additionally, he worked as a Professor at Katholieke Universiteit Leuven.
Dr. Winderickx's education includes a doctorate degree from Katholieke Universiteit Leuven.
Aktive Positionen von Joris Winderickx
| Unternehmen | Position | Beginn |
|---|---|---|
reMYND NV
 reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | Corporate Officer/Principal | 30.05.2012 |
Ehemalige bekannte Positionen von Joris Winderickx
| Unternehmen | Position | Ende |
|---|---|---|
| Royal Flemish Chemical Society | Gründer | - |
ADx NeuroSciences NV
 ADx NeuroSciences NV BiotechnologyHealth Technology ADx NeuroSciences NV develops proprietary state-of-the-art biomarker-assays diagnosing a wide variety of neurodegenerative diseases and conditions. The ADx tests provide unique access to early detection of Alzheimer's disease, Parkinson's disease, and traumatic brain injury. The company was founded in 2011 by Paul Appermont, Koen Dewaele, Hugo Vanderstichele and Eugeen Vanmechelen and is headquartered in Ghent, Belgium. | Direktor/Vorstandsmitglied | - |
| Katholieke Universiteit Leuven | Corporate Officer/Principal | - |
Ausbildung von Joris Winderickx
| Katholieke Universiteit Leuven | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
reMYND NV
reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | Commercial Services |
| Royal Flemish Chemical Society | |
ADx NeuroSciences NV
ADx NeuroSciences NV BiotechnologyHealth Technology ADx NeuroSciences NV develops proprietary state-of-the-art biomarker-assays diagnosing a wide variety of neurodegenerative diseases and conditions. The ADx tests provide unique access to early detection of Alzheimer's disease, Parkinson's disease, and traumatic brain injury. The company was founded in 2011 by Paul Appermont, Koen Dewaele, Hugo Vanderstichele and Eugeen Vanmechelen and is headquartered in Ghent, Belgium. | Health Technology |
